Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates
Nivedita Gupta, Labanya Mukhopadhyay, Pragya D. Yadav, et al.
The Indian Journal of Medical Research (2021) Vol. 153, Iss. 1, pp. 93-93
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
Conrad En Zuo Chan, Shirley G. K. Seah, De Hoe Chye, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0253487-e0253487
Open Access | Times Cited: 92
Advances in the design and development of SARS-CoV-2 vaccines
Xue‐Liang Peng, Ji‐Si‐Yu Cheng, Hai‐Lun Gong, et al.
Military Medical Research (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 66
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategies
Wenping Gong, Seppo Parkkila, Xueqiong Wu, et al.
International Reviews of Immunology (2022) Vol. 42, Iss. 6, pp. 393-414
Open Access | Times Cited: 59
Covid-19: virology, variants, and vaccines
Megan Young, Harry Crook, J. T. Scott, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000040-e000040
Open Access | Times Cited: 43
Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management
Philippe Caron
Endocrine (2022) Vol. 78, Iss. 3, pp. 406-417
Open Access | Times Cited: 31
A Synthetic Peptide CTL Vaccine Targeting Nucleocapsid Confers Protection from SARS-CoV-2 Challenge in Rhesus Macaques
Paul E. Harris, Trevor Brasel, Christopher Massey, et al.
Vaccines (2021) Vol. 9, Iss. 5, pp. 520-520
Open Access | Times Cited: 34
Development of an Inactivated Vaccine against SARS CoV-2
Shaikh Terkıs Islam Pavel, Hazel Yetişkin, Muhammet Ali Uygut, et al.
Vaccines (2021) Vol. 9, Iss. 11, pp. 1266-1266
Open Access | Times Cited: 33
A Single Dose of an MVA Vaccine Expressing a Prefusion-Stabilized SARS-CoV-2 Spike Protein Neutralizes Variants of Concern and Protects Mice From a Lethal SARS-CoV-2 Infection
Patricia Pérez, Adrián Lázaro-Frías, Carmen Zamora, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 23
SARS-CoV-2 in lions, gorillas and zookeepers in the Rotterdam Zoo, the Netherlands, a One Health investigation, November 2021
Florien Dusseldorp, Linda G. R. Bruins-van Sonsbeek, Maaike Buskermolen, et al.
Eurosurveillance (2023) Vol. 28, Iss. 28
Open Access | Times Cited: 13
Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges
Ramesh Kandimalla, Pratik Chakraborty, V. Jayalakshmi, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1740-1740
Open Access | Times Cited: 24
Development of animal models for emerging infectious diseases by breaking the barrier of species susceptibility to human pathogens
Na Rong, Jiangning Liu
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Vaccines against SARS-CoV-2 variants and future pandemics
Taeyoung Park, Hyogyeong Hwang, Suhyeong Moon, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 10, pp. 1363-1376
Open Access | Times Cited: 15
Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge
Martin Sebastian Winkler, Tomasz Skirecki, Frank M. Brunkhorst, et al.
EBioMedicine (2021) Vol. 66, pp. 103291-103291
Open Access | Times Cited: 19
SARS-CoV-2: Pathogenesis, Molecular Targets and Experimental Models
G. Kanimozhi, B. Pradhapsingh, Charan Singh Pawar, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 19
Assessment of immunogenicity and protective efficacy of ZyCoV-D DNA vaccine candidates in Rhesus macaques against SARS-CoV-2 infection
Pragya D. Yadav, Sanjay Kumar, K N Agarwal, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 16
Vaccine against COVID-19
Juan J. Picazo
Revista Española de Quimioterapia (2021), pp. 569-598
Open Access | Times Cited: 14
Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms
Maryam Bayat, Yahya Asemani, Sajad Najafi
International Immunopharmacology (2021) Vol. 97, pp. 107679-107679
Open Access | Times Cited: 12
Immunization with a Prefusion SARS-CoV-2 Spike Protein Vaccine (RBMRNA-176) Protects against Viral Challenge in Mice and Nonhuman Primates
Qinhai Ma, Runfeng Li, Jianmin Guo, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1698-1698
Open Access | Times Cited: 8
No association of vaccination with inactivated COVID‐19 vaccines before conception with pregnancy complications and adverse birth outcomes: A cohort study of 5457 Chinese pregnant women
Yan Zhao, Yongbo Zhao, Xin Su, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 4
Inactivated COVID-19 vaccines in peri-pregnancy period: Evaluation of safety for both pregnant women and neonates
Caihua Yang, Zengyue Zheng, Ping Zheng, et al.
Vaccine (2023) Vol. 41, Iss. 49, pp. 7450-7459
Closed Access | Times Cited: 4
A synthetic peptide CTL vaccine targeting nucleocapsid confers protection from SARS-CoV-2 challenge in rhesus macaques
Paul E. Harris, Trevor Brasel, Christopher Massey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
Counting on COVID-19 vaccine: Insights into the current strategies, progress and future challenges
Ramesh Kandimalla, Pratik Chakraborthy, V. Jayalakshmi, et al.
(2021)
Closed Access | Times Cited: 8
Successive Site Translocating Inoculation Improved T Cell Responses Elicited by a DNA Vaccine Encoding SARS-CoV-2 S Protein
Xiangxiang Tian, Yifan Zhang, Zhangyufan He, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
SARS‐CoV‐2 does not infect pigs, but this has to be verified regularly
Tanja Opriessnig, Yao‐Wei Huang
Xenotransplantation (2022) Vol. 29, Iss. 5
Open Access | Times Cited: 4
Infectious Disease Spreading Fought by Multiple Vaccines Having a Prescribed Time Effect
Rinaldo M. Colombo, Mauro Garavello
Acta Biotheoretica (2022) Vol. 71, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top